Participation of lectin chaperones and thiol oxidoreductases in protein folding within the endoplasmic reticulum

Current Opinion in Cell Biology

Volumn 23, Issue 2, 2011, Pages 157-166

  Rutkevich, Lori A ^a   Williams, David B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALNEXIN; CALRETICULIN; CHAPERONE; LECTIN; THIOL OXIDASE;

ENDOPLASMIC RETICULUM; HUMAN; ISOMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW;

ANIMALS; APOPTOSIS; ENDOPLASMIC RETICULUM; HUMANS; LECTINS; MOLECULAR CHAPERONES; OXIDOREDUCTASES; PROTEIN FOLDING;

EID: 79954424872     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2010.10.011     Document Type: Review

References (73)

1. Hammond C., Braakman I., Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci USA 1994, 91:913-917.
2. Spiro R.G., Zhu Q., Bhoyroo V., Soling H.D. Definition of the lectin-like properties of the molecular chaperone, calreticulin, and demonstration of its copurification with endomannosidase from rat liver Golgi. J Biol Chem 1996, 271:11588-11594.
3. Ware F.E., Vassilakos A., Peterson P.A., Jackson M.R., Lehrman M.A., Williams D.B. The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J Biol Chem 1995, 270:4697-4704.
4. Jackson M.R., Cohen-Doyle M.F., Peterson P.A., Williams D.B. Regulation of MHC class I transport by the molecular chaperone, calnexin (p88, IP90). Science 1994, 263:384-387.
5. Hebert D.N., Foellmer B., Helenius A. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J 1996, 15:2961-2968.
6. Molinari M., Eriksson K.K., Calanca V., Galli C., Cresswell P., Michalak M., Helenius A. Contrasting functions of calreticulin and calnexin in glycoprotein folding and ER quality control. Mol Cell 2004, 13:125-135.
7. Vassilakos A., Cohen-Doyle M.F., Peterson P.A., Jackson M.R., Williams D.B. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J 1996, 15:1495-1506.
8. Frickel E.M., Riek R., Jelesarov I., Helenius A., Wuthrich K., Ellgaard L. TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc Natl Acad Sci USA 2002, 99:1954-1959.
9. Oliver J.D., van der Wal F.J., Bulleid N.J., High S. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 1997, 275:86-88.
10. Schrag J.D., Bergeron J.J., Li Y., Borisova S., Hahn M., Thomas D.Y., Cygler M. The structure of calnexin, an ER chaperone involved in quality control of protein folding. Mol Cell 2001, 8:633-644.
11. Brockmeier A., Williams D.B. Potent lectin-independent chaperone function of calnexin under conditions prevalent within the lumen of the endoplasmic reticulum. Biochemistry 2006, 45:12906-12916.
12. Li Z., Stafford W.F., Bouvier M. The metal ion binding properties of calreticulin modulate its conformational flexibility and thermal stability. Biochemistry 2001, 40:11193-11201.
13. Ellgaard L., Riek R., Herrmann T., Guntert P., Braun D., Helenius A., Wuthrich K. NMR structure of the calreticulin P-domain. Proc Natl Acad Sci USA 2001, 98:3133-3138.
14. Kozlov G., Pocanschi C.L., Rosenauer A., Bastos-Aristizabal S., Gorelik A., Williams D.B., Gehring K. Structural basis of carbohydrate recognition by calreticulin. J Biol Chem 2010, 285:38612-38620.
15. Vassilakos A., Michalak M., Lehrman M.A., Williams D.B. Oligosaccharide binding characteristics of the molecular chaperones calnexin and calreticulin. Biochemistry 1998, 37:3480-3490.
16. Kapoor M., Ellgaard L., Gopalakrishnapai J., Schirra C., Gemma E., Oscarson S., Helenius A., Surolia A. Mutational analysis provides molecular insight into the carbohydrate-binding region of calreticulin: pivotal roles of tyrosine-109 and aspartate-135 in carbohydrate recognition. Biochemistry 2004, 43:97-106.
17. Thomson S.P., Williams D.B. Delineation of the lectin site of the molecular chaperone calreticulin. Cell Stress Chaperones 2005, 10:242-251.
18. Deprez P., Gautschi M., Helenius A. More than one glycan is needed for ER glucosidase II to allow entry of glycoproteins into the calnexin/calreticulin cycle. Mol Cell 2005, 19:183-195.
19. Grinna L.S., Robbins P.W. Substrate specificities of rat liver microsomal glucosidases which process glycoproteins. J Biol Chem 1980, 255:2255-2258.
20. Totani K., Ihara Y., Matsuo I., Ito Y. Substrate specificity analysis of endoplasmic reticulum glucosidase II using synthetic high mannose-type glycans. J Biol Chem 2006, 281:31502-31508.
21. Caramelo J.J., Castro O.A., de Prat-Gay G., Parodi A.J. The endoplasmic reticulum glucosyltransferase recognizes nearly native glycoprotein folding intermediates. J Biol Chem 2004, 279:46280-46285.
22. Ritter C., Quirin K., Kowarik M., Helenius A. Minor folding defects trigger local modification of glycoproteins by the ER folding sensor GT. EMBO J 2005, 24:1730-1738.
23. Taylor S.C., Ferguson A.D., Bergeron J.J., Thomas D.Y. The ER protein folding sensor UDP-glucose glycoprotein-glucosyltransferase modifies substrates distant to local changes in glycoprotein conformation. Nat Struct Mol Biol 2004, 11:128-134.
24. Totani K., Ihara Y., Matsuo I., Koshino H., Ito Y. Synthetic substrates for an endoplasmic reticulum protein-folding sensor, UDP-glucose: glycoprotein glucosyltransferase. Angew Chem Int Ed Engl 2005, 44:7950-7954.
25. Sousa M.C., Ferrero-Garcia M.A., Parodi A.J. Recognition of the oligosaccharide and protein moieties of glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. Biochemistry 1992, 31:97-105.
26. Solda T., Galli C., Kaufman R.J., Molinari M. Substrate-specific requirements for UGT1-dependent release from calnexin. Mol Cell 2007, 27:238-249.
27. Williams D.B. Beyond lectins: the calnexin/calreticulin chaperone system of the endoplasmic reticulum. J Cell Sci 2006, 119:615-623.
28. Brockmeier A., Brockmeier U., Williams D.B. Distinct contributions of the lectin and arm domains of calnexin to its molecular chaperone function. J Biol Chem 2009, 284:3433-3444.
29. Sandhu N., Duus K., Jorgensen C.S., Hansen P.R., Bruun S.W., Pedersen L.O., Hojrup P., Houen G. Peptide binding specificity of the chaperone calreticulin. Biochim Biophys Acta 2007, 1774:701-713.
30. Ireland B.S., Brockmeier U., Howe C.M., Elliott T., Williams D.B. Lectin-deficient calreticulin retains full functionality as a chaperone for class I histocompatibility molecules. Mol Biol Cell 2008, 19:2413-2423.
31. Leach M.R., Williams D.B. Lectin-deficient calnexin is capable of binding class I histocompatibility molecules in vivo and preventing their degradation. J Biol Chem 2004, 279:9072-9079.
32. Del Cid N., Jeffery E., Rizvi S.M., Stamper E., Peters L.R., Brown W.C., Provoda C., Raghavan M. Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway. J Biol Chem 2010, 285:4520-4535.
33. Mesaeli N., Nakamura K., Zvaritch E., Dickie P., Dziak E., Krause K.H., Opas M., MacLennan D.H., Michalak M. Calreticulin is essential for cardiac development. J Cell Biol 1999, 144:857-868.
34. Molinari M., Galli C., Vanoni O., Arnold S.M., Kaufman R.J. Persistent glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay aggregation and loss of folding competence. Mol Cell 2005, 20:503-512.
35. Kraus A., Groenendyk J., Bedard K., Baldwin T.A., Krause K.H., Dubois-Dauphin M., Dyck J., Rosenbaum E.E., Korngut L., Colley N.J., et al. Calnexin deficiency leads to dysmyelination. J Biol Chem 2010, 285:18928-18938.
36. Denzel A., Molinari M., Trigueros C., Martin J.E., Velmurgan S., Brown S., Stamp G., Owen M.J. Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression. Mol Cell Biol 2002, 22:7398-7404.
37. Pieren M., Galli C., Denzel A., Molinari M. The use of calnexin and calreticulin by cellular and viral glycoproteins. J Biol Chem 2005, 280:28265-28271.
38. Allen S., Bulleid N.J. Calnexin and calreticulin bind to enzymically active tissue-type plasminogen activator during biosynthesis and are not required for folding to the native conformation. Biochem J 1997, 328(Pt 1):113-119.
39. Gao B., Adhikari R., Howarth M., Nakamura K., Gold M.C., Hill A.B., Knee R., Michalak M., Elliott T. Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 2002, 16:99-109.
40. Pearse B.R., Tamura T., Sunryd J.C., Grabowski G.A., Kaufman R.J., Hebert D.N. The role of UDP-Glc:glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin. J Cell Biol 2010, 189:829-841.
41. Bass J., Chiu G., Argon Y., Steiner D.F. Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization. J Cell Biol 1998, 141:637-646.
42. Zapun A., Darby N.J., Tessier D.C., Michalak M., Bergeron J.J., Thomas D.Y. Enhanced catalysis of ribonuclease B folding by the interaction of calnexin or calreticulin with ERp57. J Biol Chem 1998, 273:6009-6012.
43. Jessop C.E., Tavender T.J., Watkins R.H., Chambers J.E., Bulleid N.J. Substrate specificity of the oxidoreductase ERp57 is determined primarily by its interaction with calnexin and calreticulin. J Biol Chem 2009, 284:2194-2202.
44. Jessop C.E., Chakravarthi S., Garbi N., Hammerling G.J., Lovell S., Bulleid N.J. ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. EMBO J 2007, 26:28-40.
45. Solda T., Garbi N., Hammerling G.J., Molinari M. Consequences of ERp57 deletion on oxidative folding of obligate and facultative clients of the calnexin cycle. J Biol Chem 2006, 281:6219-6226.
46. Lederkremer G.Z. Glycoprotein folding, quality control and ER-associated degradation. Curr Opin Struct Biol 2009, 19:515-523.
47. Chevet E., Wong H.N., Gerber D., Cochet C., Fazel A., Cameron P.H., Gushue J.N., Thomas D.Y., Bergeron J.J. Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes. EMBO J 1999, 18:3655-3666.
48. Cameron P.H., Chevet E., Pluquet O., Thomas D.Y., Bergeron J.J. Calnexin phosphorylation attenuates the release of partially misfolded alpha1-antitrypsin to the secretory pathway. J Biol Chem 2009, 284:34570-34579.
49. Hayashi T., Rizzuto R., Hajnoczky G., Su T.P. MAM: more than just a housekeeper. Trends Cell Biol 2009, 19:81-88.
50. Myhill N., Lynes E.M., Nanji J.A., Blagoveshchenskaya A.D., Fei H., Carmine Simmen K., Cooper T.J., Thomas G., Simmen T. The subcellular distribution of calnexin is mediated by PACS-2. Mol Biol Cell 2008, 19:2777-2788.
51. Maattanen P., Gehring K., Bergeron J.J., Thomas D.Y. Protein quality control in the ER: the recognition of misfolded proteins. Semin Cell Dev Biol 2010, 21:500-511.
52. Hatahet F., Ruddock L.W., Ahn K., Benham A., Craik D., Ellgaard L., Ferrari D., Ventura S. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal 2009, 11:2807-2850.
53. Kulp M.S., Frickel E.M., Ellgaard L., Weissman J.S. Domain architecture of protein-disulfide isomerase facilitates its dual role as an oxidase and an isomerase in Ero1p-mediated disulfide formation. J Biol Chem 2006, 281:876-884.
54. Appenzeller-Herzog C., Ellgaard L. In vivo reduction-oxidation state of protein disulfide isomerase: the two active sites independently occur in the reduced and oxidized forms. Antioxid Redox Signal 2008, 10:55-64.
55. Karala A.R., Lappi A.K., Ruddock L.W. Modulation of an active-site cysteine pKa allows PDI to act as a catalyst of both disulfide bond formation and isomerization. J Mol Biol 2010, 396:883-892.
56. Tian G., Xiang S., Noiva R., Lennarz W.J., Schindelin H. The crystal structure of yeast protein disulfide isomerase suggests cooperativity between its active sites. Cell 2006, 124:61-73.
57. Byrne L.J., Sidhu A., Wallis A.K., Ruddock L.W., Freedman R.B., Howard M.J., Williamson R.A. Mapping of the ligand-binding site on the b′ domain of human PDI: interaction with peptide ligands and the x-linker region. Biochem J 2009, 423:209-217.
58. Denisov A.Y., Maattanen P., Dabrowski C., Kozlov G., Thomas D.Y., Gehring K. Solution structure of the bb′ domains of human protein disulfide isomerase. FEBS J 2009, 276:1440-1449.
59. Tian G., Kober F.X., Lewandrowski U., Sickmann A., Lennarz W.J., Schindelin H. The catalytic activity of protein-disulfide isomerase requires a conformationally flexible molecule. J Biol Chem 2008, 283:33630-33640.
60. Nguyen V.D., Wallis K., Howard M.J., Haapalainen A.M., Salo K.E., Saaranen M.J., Sidhu A., Wierenga R.K., Freedman R.B., Ruddock L.W., et al. Alternative conformations of the x region of human protein disulphide-isomerase modulate exposure of the substrate binding b′ domain. J Mol Biol 2008, 383:1144-1155.
61. Wang L., Vavassori S., Li S., Ke H., Anelli T., Degano M., Ronzoni R., Sitia R., Sun F., Wang C.C. Crystal structure of human ERp44 shows a dynamic functional modulation by its carboxy-terminal tail. EMBO Rep 2008, 9:642-647.
62. Maattanen P., Kozlov G., Gehring K., Thomas D.Y. ERp57 and PDI: multifunctional protein disulfide isomerases with similar domain architectures but differing substrate-partner associations. Biochem Cell Biol 2006, 84:881-889.
63. Kozlov G., Maattanen P., Schrag J.D., Pollock S., Cygler M., Nagar B., Thomas D.Y., Gehring K. Crystal structure of the bb′ domains of the protein disulfide isomerase ERp57. Structure 2006, 14:1331-1339.
64. Wearsch P.A., Cresswell P. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol 2007, 8:873-881.
65. Dong G., Wearsch P.A., Peaper D.R., Cresswell P., Reinisch K.M. Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity 2009, 30:21-32.
66. Kozlov G., Maattanen P., Schrag J.D., Hura G.L., Gabrielli L., Cygler M., Thomas D.Y., Gehring K. Structure of the noncatalytic domains and global fold of the protein disulfide isomerase ERp72. Structure 2009, 17:651-659.
67. Kozlov G., Azeroual S., Rosenauer A., Maattanen P., Denisov A.Y., Thomas D.Y., Gehring K. Structure of the catalytic a(0)a fragment of the protein disulfide isomerase ERp72. J Mol Biol 2010, 401:618-625.
68. Jessop C.E., Watkins R.H., Simmons J.J., Tasab M., Bulleid N.J. Protein disulphide isomerase family members show distinct substrate specificity: P5 is targeted to BiP client proteins. J Cell Sci 2009, 122:4287-4295.
69. Norgaard P., Westphal V., Tachibana C., Alsoe L., Holst B., Winther J.R. Functional differences in yeast protein disulfide isomerases. J Cell Biol 2001, 152:553-562.
70. Rutkevich L.A., Cohen-Doyle M.F., Brockmeier U., Williams D.B. Functional relationship between protein disulfide isomerase family members during the oxidative folding of human secretory proteins. Mol Biol Cell 2010, 21:3093-3105.
71. Ushioda R., Hoseki J., Araki K., Jansen G., Thomas D.Y., Nagata K. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science 2008, 321:569-572.
72. Pirneskoski A., Klappa P., Lobell M., Williamson R.A., Byrne L., Alanen H.I., Salo K.E., Kivirikko K.I., Freedman R.B., Ruddock L.W. Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J Biol Chem 2004, 279:10374-10381.
73. Mazzarella R.A., Srinivasan M., Haugejorden S.M., Green M. ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J Biol Chem 1990, 265:1094-1101.